Nitric oxide (NO) exerts multiple functions in many life processes and was of great significance in a variety of biomedical scenarios. However, the mismatches between releasing locations and NO active sites seriously limited the available NO at areas of interest and greatly dampen the overall efficiency of delivery systems. Therefore, in the present study, a NO donor was developed to achieve intracellular delivery and release of NO to overcome the aforementioned challenges. Enhanced uptake and effective intracellular release of NO were realized via β-cyclodextrin (β-CD) mediated endocytosis and high level glutathione (GSH) inside cells, respectively. We demonstrated that intracellularly delivered NO would exert stronger bioeffects than premature release of NO outside targeted cells. Besides, β-CD assisted cellular uptake proved indispensable in maximizing the influence of NO in modulating cellular behavior. These results demonstrated the significance of intracellular delivery and release of NO in improving its bioutilization. The carrier could efficiently inhibit proliferation of SMCs, while promoting the growth of ECs. Such cell-type-differed physiological effects were advantageous in re-endothelialization and might hold great potential in cardiovascular applications.
一氧化氮(NO)在许多生命过程中发挥多种功能,在各种
生物医学场景中具有重要意义。然而,释放位置和NO活性位点之间的不匹配严重限制了感兴趣区域的可用NO,并极大地降低了传递系统的整体效率。因此,在本研究中,开发了NO供体来实现NO的细胞内递送和释放,以克服上述挑战。分别通过细胞内β-
环糊精(β-CD)介导的内吞作用和高
水平
谷胱甘肽(GSH)实现NO的增强摄取和有效的细胞内释放。我们证明,细胞内递送的 NO 比在靶细胞外过早释放 NO 会产生更强的
生物效应。此外,β-CD 辅助细胞摄取被证明对于最大化 NO 在调节细胞行为中的影响是不可或缺的。这些结果证明了细胞内递送和释放NO对于提高其
生物利用度的重要性。该载体能够有效抑制SMCs的增殖,同时促进
ECs的生长。这种细胞类型不同的生理效应有利于再内皮化,并且可能在心血管应用中具有巨大潜力。